Astronomers from the Aryabhatta Research Institute of Observational Sciences (ARIES) in India and elsewhere have conducted a ...
PALO ALTO, Calif., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Orbus Therapeutics, Inc., a private pharmaceutical company, today announced the publication of the Phase 3 STELLAR clinical study results ...
PALO ALTO, Calif., June 05, 2017 (GLOBE NEWSWIRE) -- Orbus Therapeutics Inc., a private, clinical-stage biopharmaceutical company focused on the development and commercialization of therapies that ...
New observations of the red giant star R Doradus suggest starlight alone cannot drive stellar winds that spread key elements through the galaxy.
– Updated results based on molecular classification and blinded independent central review demonstrate clinically meaningful survival benefits for patients with recurrent grade 3 astrocytoma who were ...
Morning Overview on MSN
Stars may spread life’s ingredients differently than we thought, study says
For decades, astronomers treated starlight and dust as a simple conveyor belt, a steady wind that carried the raw ingredients ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that STELLAR-3, a Phase 3, randomized, double-blind, placebo-controlled study evaluating the safety and ...
(MENAFN- GlobeNewsWire - Nasdaq) – Eflornithine and lomustine combination doubled progression free survival (PFS) and improved overall survival (OS) in patients with recurrent Grade 3 astrocytoma – ...
The MarketWatch News Department was not involved in the creation of this content. -- Updated results based on molecular classification and blinded independent central review demonstrate clinically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback